Sedana Medical
Sedana Medical AB is a Swedish medical technology and pharmaceutical company focused on inhaled sedation in intensive care units. The company develops and markets the AnaConDa medical device alongside its proprietary pharmaceutical formulation Sedaconda, transforming intravenous sedation into inhaled sedation. Main revenue drivers comprise sales of the Sedaconda medical device line, pharmaceutical supply sales, and accessories to hospital intensive care departments. Sedana Medical serves intensive care physicians, critical care units, anesthesiologists, and hospital networks across Europe and international expansion markets. The company holds a pioneering market position as the sole provider of inhaled sedation solutions for intensive care patients. Headquartered in Danderyd, Sweden, Sedana Medical AB is listed on Nasdaq Stockholm.
5 of the funds FundTelligence covers report a position in Sedana Medical.
- Legal name
- Sedana Medical AB
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 5
Funds holding Sedana Medical
- Lannebo Sweden Micro Cap — Lannebo · 0.55 % (full portfolio disclosed, June 2026)
- Lannebo Sweden All Cap — Lannebo · 0.5 % (full portfolio disclosed, June 2026)
- Handelsbanken Norden Index Criteria — Handelsbanken · 0.03 % (full portfolio disclosed, October 2026)
- Storebrand Sverige Småbolag Plus — Storebrand · 0.03 % (full portfolio disclosed, October 2026)
- Storebrand Sverige Plus — Storebrand · 0.01 % (full portfolio disclosed, October 2026)